Skip to main content Accessibility help
×
Home
Hostname: page-component-5c569c448b-t6r6x Total loading time: 0.434 Render date: 2022-07-04T22:48:30.818Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

Authors' reply

Published online by Cambridge University Press:  02 January 2018

Magali Haas
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium. Email: mhaas8@its.jnj.com
Marielle Eerdekens
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Pharmaceutica NV
Affiliation:
Beerse, Belgium
Stuart Kushner
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Julia Singer
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Ilse Augustyns
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen
Pharmaceutica NV
Affiliation:
(deceased)
Vivek Kusumakar
Affiliation:
(deceased)
Jorge Quiroz
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Gahan Pandina
Affiliation:
Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, USA
Rights & Permissions[Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © Royal College of Psychiatrists, 2009 

References

1 Aman, MG, De Smedt, G, Derivan, A, Findling, RL, Group RDBS. Double-blind, placebo-controlled study of risperidone in the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002; 159: 1337–46.CrossRefGoogle Scholar
2 Reyes, M, Buitelaar, J, Toren, P, Augustyns, I, Eerdekens, M. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders. Am J Psychiatry 2006; 163: 402–10.CrossRefGoogle ScholarPubMed
3 Stroup, TS, Alves, WM, Hamer, RM, Lieberman, JA. Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations. Nature Rev 2006; 5: 133–46.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.
You have Access

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Authors' reply
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

Authors' reply
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

Authors' reply
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *